NCT07080567View on ClinicalTrials.gov

Manipulating the Peri-Infarct Area Using Maraviroc to Enhance Motor Skills After Stroke

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 14, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Ischemic StrokeStrokeStroke Acute
Interventions
DRUG

Maraviroc

Maraviroc (300mg) twice daily for 90 days

DRUG

Mannitol

Placebo intervention

Trial Locations (1)

Unknown

RECRUITING

Geneva University Hospital, Geneva

All Listed Sponsors
lead

Emmanuel Carrera

OTHER

NCT07080567 - Manipulating the Peri-Infarct Area Using Maraviroc to Enhance Motor Skills After Stroke | Biotech Hunter | Biotech Hunter